secwatch.observer — SEC 8-K summary
======================================

Issuer:     KYNTRA BIO, INC. (KYNB)
CIK:        0000921299
Form:       8-K
Filed at:   2025-04-04T23:59:59+00:00
Accession:  0000950170-25-051219
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroGen amends bylaws to lower stockholder quorum to one-third from majority
-----------------------------------------------------------------------------

- Board adopted Amended and Restated Bylaws effective April 2, 2025.
- Quorum reduced to holders of at least one-third of outstanding shares, down from majority.
- Separate class quorum also changed to one-third of voting power.
- Amendment applies to all stockholder meetings; no other bylaw changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921299/000095017025051219/0000950170-25-051219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921299/000095017025051219/fgen-20250402.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-051219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer